CERT1 and cancer: As an excessive conversion of ceramide correlates with resistance of cancer cells to drugs and chemotherapy [29], promising anti-oncogenic therapeutic approaches rely on the ability of acting on (and blocking) CERT-mediated ceramide transfer [30]; on the other hand, a lack of CERT can induce cellular dysfunctions [31].